» Articles » PMID: 21037566

Structural Basis for the Unfolding of Anthrax Lethal Factor by Protective Antigen Oligomers

Overview
Date 2010 Nov 2
PMID 21037566
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

The protein transporter anthrax lethal toxin is composed of protective antigen (PA), a transmembrane translocase, and lethal factor (LF), a cytotoxic enzyme. After its assembly into holotoxin complexes, PA forms an oligomeric channel that unfolds LF and translocates it into the host cell. We report the crystal structure of the core of a lethal toxin complex to 3.1-Å resolution; the structure contains a PA octamer bound to four LF PA-binding domains (LF(N)). The first α-helix and β-strand of each LF(N) unfold and dock into a deep amphipathic cleft on the surface of the PA octamer, which we call the α clamp. The α clamp possesses nonspecific polypeptide binding activity and is functionally relevant to efficient holotoxin assembly, PA octamer formation, and LF unfolding and translocation. This structure provides insight into the mechanism of translocation-coupled protein unfolding.

Citing Articles

Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.

Ruschig M, Marschall A BioDrugs. 2023; 37(2):181-203.

PMID: 36729328 PMC: 9893211. DOI: 10.1007/s40259-023-00580-y.


Solution Structures of Protective Antigen Proteins Using Small Angle Neutron Scattering and Protective Antigen 63 Ion Channel Formation Kinetics.

Michelman-Ribeiro A, Rubinson K, Silin V, Kasianowicz J Toxins (Basel). 2021; 13(12).

PMID: 34941724 PMC: 8708185. DOI: 10.3390/toxins13120888.


Thermodynamic Stability Is a Strong Predictor for the Delivery of DARPins to the Cytosol via Anthrax Toxin.

Becker L, Singh Badwal J, Brandl F, Verdurmen W, Pluckthun A Pharmaceutics. 2021; 13(8).

PMID: 34452246 PMC: 8401532. DOI: 10.3390/pharmaceutics13081285.


Anthrax toxin translocation complex reveals insight into the lethal factor unfolding and refolding mechanism.

Machen A, Fisher M, Freudenthal B Sci Rep. 2021; 11(1):13038.

PMID: 34158520 PMC: 8219829. DOI: 10.1038/s41598-021-91596-3.


Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology.

Shilova O, Shramova E, Proshkina G, Deyev S Int J Mol Sci. 2021; 22(9).

PMID: 34067057 PMC: 8124712. DOI: 10.3390/ijms22094975.


References
1.
Duesbery N, Webb C, Leppla S, Gordon V, Klimpel K, Copeland T . Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998; 280(5364):734-7. DOI: 10.1126/science.280.5364.734. View

2.
Melnyk R, Hewitt K, Lacy D, Lin H, Gessner C, Li S . Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen. J Biol Chem. 2005; 281(3):1630-5. DOI: 10.1074/jbc.M511164200. View

3.
Meador W, Means A, Quiocho F . Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. Science. 1993; 262(5140):1718-21. DOI: 10.1126/science.8259515. View

4.
Cheng Y . Toward an atomic model of the 26S proteasome. Curr Opin Struct Biol. 2009; 19(2):203-8. PMC: 2743420. DOI: 10.1016/j.sbi.2009.02.004. View

5.
Wickner W, Schekman R . Protein translocation across biological membranes. Science. 2005; 310(5753):1452-6. DOI: 10.1126/science.1113752. View